Vaxart(VXRT)
SOUTH SAN FRANCISCO, CABiotechnology
Focus: Vaxart is a public biotech company pioneering oral vaccine delivery for infectious diseases including influenza, RSV, COVID-19, and norovirus. The company operates at pre-commercial stage with a diversified pipeline but minimal near-term revenue.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Vaxart?
AI assessmentVaxart offers high-risk/high-reward opportunity for scientists committed to novel vaccine modalities, but significant clinical validation and financial execution risks exist before career stability materializes.
Why Work Here
- Proprietary oral vaccine platform represents differentiated technology in a major vaccine market expansion opportunity post-COVID
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
40 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$29M
Key Products
BTA-C585 oral capsule
Stable
Growth
Lead Phase 2 RSV program; oral delivery addresses major unmet need in respiratory vaccines.
VXA-CoV2-1.1-S
Help build intelligence for Vaxart
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.